Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioharvest Sciences (BHST) Cash from Operations (2023 - 2025)

Bioharvest Sciences has reported Cash from Operations over the past 3 years, most recently at 2252000.0 for Q4 2025.

  • For Q4 2025, Cash from Operations rose 5.73% year-over-year to 2252000.0; the TTM value through Dec 2025 reached 7226000.0, down 8.11%, while the annual FY2025 figure was 7226000.0, 8.11% down from the prior year.
  • Cash from Operations was 2252000.0 for Q4 2025 at Bioharvest Sciences, down from 2091000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 958000.0 in Q2 2024 and bottomed at 2994000.0 in Q4 2023.
  • The 3-year median for Cash from Operations is 1668500.0 (2024), against an average of 1789900.0.
  • The widest YoY moves for Cash from Operations: up 20.21% in 2024, down 76.78% in 2024.
  • Over 3 years, Cash from Operations stood at 2994000.0 in 2023, then rose by 20.21% to 2389000.0 in 2024, then rose by 5.73% to 2252000.0 in 2025.
  • The last three reported values for Cash from Operations were 2252000.0 (Q4 2025), 2091000.0 (Q3 2025), and 1456000.0 (Q2 2025) per Business Quant data.